This $2,559,308 Project Grant was awarded on January 14, 2025 by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The grant supports a study examining the impact of severe pre-eclampsia on heart function in a racially diverse cohort of women during and after pregnancy. The study aims to characterize the cardiomyopathic genetic profile of participants and assess the functional impact of specific genetic...
This Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program provides $168,480 to support a research study conducted by Ann & Robert H. Lurie Children's Hospital of Chicago. The study aims to investigate prenatal care utilization pathways, the impact of social determinants of health on access to care, and the effects of prenatal care on postnatal healthcare utilization and expenditures for publicly...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund research to understand disparities in the incidence, outcomes, and post-partum care of hypertensive disorders of pregnancy (HDP). The $502,069 award to Mayo Clinic, a non-profit academic medical center, will quantify the moderating effect of socioeconomic status (SES) on the relationship between urban/rural status and HDP. The research...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will provide $602,099 to the Icahn School of Medicine at Mount Sinai to conduct a longitudinal study on the impact of structural racism during pregnancy on future cardiopulmonary health outcomes. The study, titled "The Impact of Structural Racism During Pregnancy on Future Cardiopulmonary Health" (Gen C Mamas), will follow 440...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $536,142 to Saint Luke's Hospital of Kansas City to conduct the IQ-CART study. The study aims to assess whether participation in Resuscitation Academy training is associated with improved survival rates for out-of-hospital cardiac arrest (OHCA) at Emergency Medical Service (EMS) agencies. The key activities include a prospective...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is funding a $1,383,783 research project to identify optimal dietary patterns for preventing postpartum cardiovascular disease. The University of Pittsburgh is the primary awardee, with a sub-award to Emory University. The research aims to establish the role of longitudinal dietary patterns in developing cardiovascular disease and risk factors...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $103,948 to the University of Denver to conduct a longitudinal study examining the association between discrimination reported during pregnancy and later cardiovascular disease (CVD) risk in mothers. The 19-month project aims to: 1) test whether greater discrimination during pregnancy is associated with greater overall maternal...
The National Heart Lung and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $727,080 Project Grant to the University of South Carolina to investigate the neurogenic mechanisms underlying the relationship between psychosocial stress, postpartum cardiovascular disease, and postpartum depression. The 4-year research project aims to delineate how stress-induced mitochondrial dysfunction in the medial prefrontal cortex contributes to postpartum...
This Project Grant award of $777,954 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund a mixed-method study to assess the impact of school environment attributes on adolescent cardiovascular risk and maternal morbidity. The primary objectives are to: 1) create a school-based adolescent preconception cohort by linking school environment, adolescent health, and Medicaid birth data; 2) engage adolescents and...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $869,696 to Vanderbilt University Medical Center to investigate the relationship between preeclampsia during pregnancy and the development of heart failure with preserved ejection fraction (HFpEF) in women. The key objectives are to: 1) measure the relationship between post-partum subclinical left ventricular diastolic dysfunction and...